Mirum Pharmaceuticals, Inc. Share Price
NASDAQ: MIRM | Mid CapMirum Pharmaceuticals, Inc. Stock Performance
Mirum Pharmaceuticals, Inc. Share Price Today
As of 30 October 2026, Mirum Pharmaceuticals, Inc.'s share price is $86.38. The stock opened at $87.78, compared to its previous close of $85.68. During today's trading session, Mirum Pharmaceuticals, Inc.'s share price traded between $84.94 and $88.39, with an average price of $86.67. Over the past 52 weeks, the stock has recorded a high of $129.78 and a low of $63.34. In terms of performance, Mirum Pharmaceuticals, Inc.'s share price has declined by 11.29% over the last six months and is up 18.88% on a year-on-year basis.
Mirum Pharmaceuticals, Inc. Share Price Chart
Mirum Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Mirum Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
Mirum Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $85.22 | $86.40 | +1.09% |
Sep 2026 | $98.00 | $85.47 | -14.27% |
Aug 2026 | $103.91 | $99.70 | -5.77% |
Jul 2026 | $118.68 | $105.81 | -9.53% |
Jun 2026 | $99.48 | $116.95 | +15.18% |
May 2026 | $96.34 | $101.54 | +4.28% |
Apr 2026 | $94.44 | $97.37 | +5.38% |
Mar 2026 | $89.20 | $92.40 | +0.15% |
Feb 2026 | $102.45 | $92.27 | -10.64% |
Jan 2026 | $78.74 | $103.25 | +30.79% |
Dec 2025 | $73.15 | $78.95 | +8.14% |
Nov 2025 | $71.77 | $73.01 | +0.48% |